Bruce Carter

Bruce Carter

Vermögen: - $ am 31.10.2026

82 Jahre
Health Technology
Commercial Services
Finance

Profil

Bruce Leonard Andrews Carter currently works at Enanta Pharmaceuticals, Inc., as Chairman from 2015, ALSP Orchid Acquisition Corp.
I, as Chairman, Dr. Reddy's Laboratories, Inc., as Director, Aurigene Oncology Ltd., as Independent Director, the University of Washington, as Professor from 1986, and Accelerator Services Corp, as Senior Advisor.
Dr. Carter also formerly worked at ZymoGenetics, Inc., as Chairman from 2009 to 2010, Global Alliance for TB Drug Development, as Executive Chairman in 2013, Xencor, Inc., as Chairman from 2009 to 2017, Immune Design Corp., as Executive Chairman from 2009 to 2011, Infectious Disease Research Institute, as Executive Chairman in 2011, Infectious Disease Research Institute, as Chairman, QLT, Inc., as Independent Director from 2006 to 2012, Dr. Reddy's Laboratories Ltd., as Independent Non-Executive Director from 2008 to 2022, Renovis, Inc., as Director from 2005 to 2008, McAdams Wright Ragen, Inc., as Director, Biothera, Inc., as Director, Moksha8 Pharmaceuticals, Inc., as Director, Ark Therapeutics Group Plc, as Non-Executive Director, Mirati Therapeutics, Inc., as Independent Director from 2016 to 2024, Regulus Therapeutics, Inc., as Independent Director from 2012 to 2015, Immune Design Corp., as Director from 2000 to 2009, Navigating Cancer, Inc., as Director, Novo Nordisk A, as Chief Scientific Officer & Executive VP from 1994 to 1998, and G.D.
Searle & Co., Inc., as Head-Molecular Genetics from 1982 to 1986.
Dr. Carter received his doctorate degree from Queen Elizabeth College and undergraduate degree from The University of Nottingham.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
11.03.2026 0 ( -.--% ) - $ 31.10.2026

Aktive Positionen von Bruce Carter

UnternehmenPositionBeginn
ENANTA PHARMACEUTICALS, INC. Vorsitzender 14.12.2015
ALSP ORCHID ACQUISITION CORPORATION I Vorsitzender -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Corporate Officer/Principal 01.01.1986
Berater -

Ehemalige bekannte Positionen von Bruce Carter

UnternehmenPositionEnde
MIRATI THERAPEUTICS Direktor/Vorstandsmitglied 23.01.2024
Vorsitzender 23.02.2023
DR. REDDY'S LABORATORIES LIMITED Direktor/Vorstandsmitglied 30.07.2022
░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Bruce Carter im Detail an

Ausbildung von Bruce Carter

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

66

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen25

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Process Industries

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Finance

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Finance

  1. Börse
  2. Insider
  3. Bruce Carter